Publikationen

2016

Ndrepepa G, Braun S, Schunkert H, Laugwitz K, Kastrati A
Gamma-glutamyl transferase and prognosis in patients with coronary artery disease. Clin Chim Acta 2016; 452:155-160

Braun D, Knipper A, Orban M, Sibbing D, Petzold T, Braun S, Schulz S, Hausleiter J, Kastrati A, Mehilli J, Massberg S
Platelet function and coagulation in patients with STEMI and peri-interventional clopidogrel plus heparin vs. prasugrel plus bivalirudin therapy (BRAVE 4 substudy). Throm Res 2016;137:72-78
 

2015

Mayer K, Orban M, Bernlochner I, Braun S, Schulz S, Gross L, Hadamitzky M, Schunkert H, Laugwitz KL, Massberg S, Kastrati A, Sibbing D
Predictors of antiplatelet response to prasugrel during maintenance treatment. Platelets 2015;26(1):53-8

Stamatelopoulos K, Sibbing D, Rallidis L, Georgiopoulos G, Stakos D, Braun S, Gatsiou A, Sopova K, Kotakos C, Varounis C, Tellis C, Kastritis E, Alevizaki M, Tselepis A, Alexopoulos P, Laske C, Keller T, Kastrati A, Dimmeler S, Zeiher A, Stellos K
Amyloid-Beta(1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease. J Am Coll Cardiol 2015;65(9):904-16

Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz K, Sibbing D, Kastrati A
The impact of therapeutic hypothermia on on-treatment platelet reacitivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry. Throm Res 2015;136(1):87-93

Grabs V, Peres T, Zelger O, Haller B, Pressler A, Braun S, Halle M, Scherr J
Decreased prevalence of cardiac arrhythmias during and after vigorous and prolonged exercise in healthy male marathon runners. Am Heart J 2015;170(1):149-55

Petersmann A, Baum H, Bietenbeck A, Braun S., Fabricius H, Freytag C, Gottschall K, Hansen C, Hiefinger-Schindlbeck R, Hubmann M, Kerkin S, Lamp S, Masch H, Montanus G, Nordmann S, Otte K, Patscheke H, Peetz D, Pick K, Rünz T, Schäfer-Lüdtke H, Schüller M, Schwenz B, Sommerhoff B, Sonntag O, Stein W, Streichert T, Vogt W, Wiegel B, Winter T, Zabel L, Nauck M
Kennen Sie Ihr Labor? Ein Weg zur Selbstbewertung in meidzinischen Laboratorien nach dem EFQM-Modell. J Lab Clin Med 2015; 39(6):411-436

Haberger S, Hauser M, Braun S, Schuster T, Ewert P, Nagdyman N, Hess J, Kaemmerer H
Prognostic value of plasma B-type natriuretic peptide in the long-term follow-up of patients with transposition of the great arteries with morphologic Right systemic ventricle after atrial switch operation. Circ J 2015 ;79(12):2677-81
 

2014

Mohlenkamp S, Leineweber K, Lehmann N, Braun S, Roggenbuck U, Perrey M, et al.
Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners. Basic research in cardiology. 2014;109(1):391.

Möhlenkamp S, Leineweber K, Lehmann N, Braun S, Roggenbuck U, Perrey M, Broecker-Preuss M, Budde T, Halle M, Mann K, Jockel K, Erbel R, Heusch G
Coronary atherosclerosis burden, but not transient elevation, predicts long-term outcome in recreational marathon runners. Basic Res Cardiol 2014;109(1):391

Wacker-Gussmann A, Buhren K, Schultheiss C, Braun S, Page S, Saugel B, Schmid S, Mair S, Schömig A, Schmid R, Huber W
Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients. Am J Roentgenol 2014; 202(2):452-58

Mayer K, Schulz S, Bernlochner I, Morath T, Braun S, Hausleiter J, Massberg S, Schunkert H, Laugwitz K, Kastrati A, Sibbing D
A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reacitivity: results of the ISAR-ASPI registry. Thromb Haemost 2014;112(2):342-51

Mayer K, Bernlochner I, Braun S, Schulz S, Orban M, Morath T, Cala L, Hoppmann P, Schunkert H, Laugwitz K, Kastrati A, Sibbing D
Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry. J Am Coll Cardiol 2014;64:863-71

Ndrepepa G, Braun S, Tada T, Guerra E, Schunkert H, Laugwitz K, Kastrati A
Comparative prognostic value of low-densitiy lipoprotein cholesterol and C-reactive protein in patients with stable coronary  artery disease treated with  percutaneous coronary intervention and chronic statin therapy. Cardiovasc Revasc Med 2014; 15(3):131-6

Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz K, Sibbing D, Kastrati A
Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Thromb Haemost 2014;112:1190-7

Ndrepepa G, Braun S, Tada T, King L, Cassese S, Fusaro M, Keta D, Kastrati A, Schmidt R
Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease. Indian J Med Res 2014; 140:392-400
 

2013

Bernecker C, Scherr J, Schinner S, Braun S, Scherbaum WA, Halle M.
Evidence for an exercise induced increase of TNF- and IL-6 in marathon runners. Scand J Med Sci Sports. 2013;23(2):207-14.

Bernlochner I, Mayer K, Morath T, Braun S, Schulz S, Schomig A, et al.
High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring. Platelets. 2013;24(6):500-2.

Bernlochner I, Mayer K, Morath T, Orban M, Schulz S, Schomig A, et al.
Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting. Thrombosis and Haemostasis. 2013;109(3):517-24.

Dietrich W, Busley R, Spannagl M, Braun S, Schuster T, Lison S. 
The Influence of Antithrombin Substitution on Heparin Sensitivity and Activation of Hemostasis During Coronary Artery Bypass Graft Surgery: A Dose-Finding Study. Anesthesia and Analgesia. 2013;116(6):1223-30.

Gertler R, Martin K, Hapfelmeier A, Tassani-Prell P, Braun S, Wiesner G.
The perioperative course of factor XIII and associated chest tube drainage in newborn and infants undergoing cardiac surgery. Pediatr Anesth. 2013;23(11):1035-41.

Hyseni A, Roest M, Braun SL, Barendrecht AD, de Groot PG, Ndrepepa G, et al.
Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. Thromb Res. 2013;131(3):198-203.

Ndrepepa G, Braun S, Cassese S, Fusaro M, King L, Kastrati A, et al.
C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention. Cardiovascular revascularization medicine : including molecular interventions. 2013;14(5):264-9.

Ndrepepa G, Braun S, King L, Cassese S, Tada T, Fusaro M, et al.
Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. Clin Sci. 2013;124(3-4):259-68.

Ndrepepa G, Braun S, King L, Fusaro M, Keta D, Cassese S, et al.
Relation of Fibrinogen Level With Cardiovascular Events in Patients With Coronary Artery Disease. American Journal of Cardiology. 2013;111(6):804-10.

Ndrepepa G, Braun S, King L, Fusaro M, Tada T, Cassese S, et al.
Uric acid and prognosis in angiography-proven coronary artery disease. European Journal of Clinical Investigation. 2013;43(3):256-66.

Ndrepepa G, Cassese S, Braun S, Fusaro M, King L, Tada T, et al. 
A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2013.

Orban M, Bernlochner I, Orban M, Mayer K, Hadamitzky M, Braun S, et al.
Antiplatelet Action of Clopidogrel and Prasugrel in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock. Journal of the American College of Cardiology. 2013;61(10):E24-E.
 

2012

Jaitner J, Morath T, Byrne RA, Braun S, Gebhard D, Bernlochner I, et al.
No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting. Circulation Cardiovascular interventions. 2012;5(1):82-8.

Ndrepepa G, Braun S, Haase H-U, Schulz S, Ranftl S, Hadamitzky M, et al.
Prognostic Value of Uric Acid in Patients With Acute Coronary Syndromes. American Journal of Cardiology. 2012;109(9):1260-5.

Roos M, Schuster T, Ndrepepa G, Baumann M, Lutz J, Braun S, et al.
Association of midregional proadrenomedullin with coronary artery stenoses, soft atherosclerotic plaques and coronary artery calcium. Heart and vessels. 2012;27(4):352-9.

Scherr J, Nieman DC, Schuster T, Habermann J, Rank M, Braun S, et al.
Nonalcoholic Beer Reduces Inflammation and Incidence of Respiratory Tract Illness. Med Sci Sports Exerc. 2012;44(1):18-26.

von Bruhl M-L, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, et al.
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. The Journal of experimental medicine. 2012;209(4):819-35.

Wiesner G, Braun S-L, Gruber M, Gertler R, Lange R, Tassani P, et al.
Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial. The Journal of antimicrobial chemotherapy. 2012;67(1):230-3.
 

2011

Boehm J, Hauner K, Grammer J, Dietrich W, Wagenpfeil S, Braun S, et al.
Tumor necrosis factor-alpha-863 C/A promoter polymorphism affects the inflammatory response after cardiac surgery. Eur J Cardio-Thorac Surg. 2011;40(1):E50-E4.

Braun SL.
Neues aus der Labormedizin. Bayerisches Ärzteblatt. 2011;66(7-8):394-401.

Clough T, Braun S, Fokin V, Ott I, Ragg S, Schadow G, et al.
Statistical Design and Analysis of Label-free LC-MS Proteomic Experiments: A Case Study of Coronary Artery Disease. Serum/Plasma Proteomics: Methods and Protocols. Methods in Molecular Biology : 728: Humana Press Inc; 2011. p. 293-319.

Gertler R, Wiesner G, Tassani-Prell P, Braun S-L, Martin K.
Are the Point-of-Care Diagnostics MULTIPLATE and ROTEM Valid in the Setting of High Concentrations of Heparin and Its Reversal With Protamine? Journal of Cardiothoracic and Vascular Anesthesia. 2011;25(6):981-6.

Jaitner J, Stegherr J, Morath T, Braun S, Bernlochner I, Schomig A, et al. 
Stability of the high on-treatment platelet reactivity phenotype over time in clopidogrel-treated patients. Thrombosis and Haemostasis. 2011;105(1):107-12.

Lison S, Dietrich W, Braun S, Boehm J, Schuster T, Englhard A, et al.
Enhanced Thrombin Generation After Cardiopulmonary Bypass Surgery. Anesthesia and Analgesia. 2011;112(1):37-45.

Merz M, BÖHm-Weigert M, Braun S, Cooper PC, Fischer R, Hickey K, et al.
Clinical multicenter evaluation of a new FXa-based Antithrombin assay. International Journal of Laboratory Hematology. 2011;33(5):498-506.

Ndrepepa G, Braun S, Mehilli J, Birkmeier KA, Byrne RA, Ott I, et al. 
Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. American Heart Journal. 2011;161(1).

Ndrepepa G, Braun S, Schomig A, Kastrati A.
Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease. Clinical Research in Cardiology. 2011;100(4):327-33.

Ndrepepa G, Braun S, Schulz S, Byrne RA, Pache J, Mehilli J, et al.
Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes. Clinica Chimica Acta. 2011;412(15-16):1350-6.

Ndrepepa G, Braun S, Schulz S, Fusaro M, Keta D, Pache J, et al.
Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina. European Journal of Clinical Investigation. 2011;41(10):1054-62.

Ndrepepa G, Braun S, Schulz S, Mehilli J, Schomig A, Kastrati A.
High-sensitivity troponin T level and angiographic severity of coronary artery disease. The American journal of cardiology. 2011;108(5):639-43.

Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al.
Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clinica Chimica Acta. 2011;412(9-10):748-54.

Scherr J, Braun S, Schuster T, Hartmann C, Moehlenkamp S, Wolfarth B, et al.
72-h Kinetics of High-Sensitive Troponin T and Inflammatory Markers after Marathon. Med Sci Sports Exerc. 2011;43(10):1819-27.

Steppich BA, Demetz G, Schulz S, von Wedel J, Pogatsa-Murray G, Braun SL, et al. 
Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction. Thromb Res. 2011;127(2):119-21.

Steppich BA, Hassenpflug M, Braun SL, Schomig K, von Beckerath O, von Beckerath N, et al.
Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis. Vasa. 2011;40(2):117-22.
 

2010

Bernlochner I, Steinhubl S, Braun S, Morath T, Jaitner J, Stegherr J, et al.
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment. Thromb Haemost. 2010;104(6):1193-200.

Bertsch T, Braun SL, Giannitis E, Knebel F, Weber M, Christ M.
Conference on clinical use of troponin T high sensitive (TnThs) on September 8, 2009 at the airport conference center, Frankfurt/Main. Clin Lab. 2010;56(7-8):355-8.

Byrne RA, Ndrepepa G, Braun S, Tiroch K, Mehilli J, Schulz S, et al.
Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2010;106(9):1212-7.

Krane M, Mazzitelli D, Schreiber U, Garzia AM, Braun S, Voss B, et al.
Lifebridge (BT)-T-2-A New Portable Cardiopulmonary Bypass System. Asaio J. 2010;56(1):52-6.

Massberg S, Grahl L, von Bruehl M-L, Manukyan D, Pfeiler S, Goosmann C, et al.
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16(8):887-96.

Schulz S, Sibbing D, Braun S, Morath T, Mehilli J, Massberg S, et al. 
Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents. American Heart Journal. 2010;160(2):355-61.

Sibbing D, Gebhard D, Koch W, Braun S, Stegherr J, Morath T, et al. 
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy. Journal of Thrombosis and Haemostasis. 2010;8(8):1685-93.

Sibbing D, Gebhard D, Koch W, Braun S, Stegherr J, Morath T, et al.
Impact and interaction of common CYP2C19 genetic variants on the antiplatelet effects of clopidogrel maintenance treatment. European Heart Journal. 2010;31:156-.

Sibbing D, Koch W, Gebhard D, Schuster T, Braun S, Stegherr J, et al.
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement. Circulation. 2010;121(4):512-8.

Sibbing D, Morath T, Braun S, Stegherr J, Mehilli J, Vogt W, et al.
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thrombosis and Haemostasis. 2010;103(1):151-9.

Sibbing D, Schulz S, Braun MD SL, Morath T, Stegherr J, Mehilli J, et al. 
Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement. Journal of Thrombosis and Haemostasis. 2010;8(2):250-6.

Sibbing D, Stegherr J, Braun S, Mehilli J, Schulz S, Seyfarth M, et al. 
A Double-Blind, Randomized Study on Prevention and Existence of a Rebound Phenomenon of Platelets After Cessation of Clopidogrel Treatment. Journal of the American College of Cardiology. 2010;55(6):558-65.

Sibbing D, von Beckerath N, Morath T, Stegherr J, Mehilli J, Sarafoff N, et al.
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel. European Heart Journal. 2010;31(10):1205-11.

Von Beckerath N, Sibbing D, Jawansky S, Braun S, Morath T, Vogt W, et al.
Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet vasodilator-stimulated phosphoprotein flow cytometry. Blood Coagulation & Fibrinolysis. 2010;21(1):46-52.

Voss B, Krane M, Jung C, Brockmann G, Braun S, Gunther T, et al.
Cardiopulmonary bypass with physiological flow and pressure curves: pulse is unnecessary! Eur J Cardio-Thorac Surg. 2010;37(1):223-31.
 

2009

Braun S, Spannagl M, Voller H.
Patient self-testing and self-management of oral anticoagulation. Analytical and Bioanalytical Chemistry. 2009;393(5):1463-71.

Braun S, Voller H, Soppa C, Taborski U. 
[Update of guidelines for patient self-management of oral anticoagulation]. Dtsch Med Wochenschr. 2009;134(14):695-700.

Braun S, von Beckerath N, Eltert J, Kastrati A, Schomig A, Vogt W, et al.
Assessment of Platelet Function in Whole Blood by Multiple Electrode Aggregometry: Transport of Samples Using a Pneumatic Tube System. Am J Clin Pathol. 2009;132(5):802-3.

Busch G, Steppich B, Sibbing D, Braun SL, Stein A, Groha P, et al.
Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention. Thrombosis and Haemostasis. 2009;101(2):340-4.

Iijima R, Byrne RA, Ndrepepa G, Braun S, Mehilli J, Berger PB, et al.
Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. Heart. 2009;95(2):107-12.

Ndrepepa G, Braun S, Iijima R, Keta D, Byrne RA, Schulz S, et al.
Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention. Clin Sci (Lond). 2009;116(8):651-8.

Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schomig A, et al. 
Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis. Journal of the American College of Cardiology. 2009;53(10):849-56.

Sibbing D, Morath T, Stegherr J, Braun S, Vogt W, Hadamitzky M, et al.
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.Thrombosis and Haemostasis. 2009;101(4):714-9.

Wessely R, Koppara T, Bradaric C, Vorpahl M, Braun S, Schulz S, et al.
Choice of Contrast Medium in Patients With Impaired Renal Function Undergoing Percutaneous Coronary Intervention. Circ-Cardiovasc Interv. 2009;2(5):430-U106.
 

2008

Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, et al.
Tranexamic Acid and Aprotinin in Primary Cardiac Operations: An Analysis of 220 Cardiac Surgical Patients Treated with Tranexamic Acid or Aprotinin. Anesthesia Analgesia. 2008;107(5):1469-78.

Ndrepepa G, Braun S, Mehilli J, Schömig A, Kastrati A.
Accuracy of N-Terminal Probrain Natriuretic Peptide to Predict Mortality or Detect Acute Ischemia in Patients with Coronary Artery Disease. Cardiology. 2008;109(4):249-57.

Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Schomig A, Kastrati A.
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. European Journal of Clinical Investigation. 2008;38(2):90-6.

Ndrepepa G, Kastrati A, Braun S, Koch W, Kolling K, Mehilli J, et al.
Circulating homocysteine levels in patients with type 2 diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases. 2008;18(1):66-73.

Roos M, Lutz J, Salmhofer H, Luppa P, Knauss A, Braun S, et al.
Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clinical Endocrinology. 2008;68(4):660-5.

Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, et al.
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thrombosis and Haemostasis 2008;99(1):121-6.

Sibbing D, Busch G, Braun S, Jawansky S, Schomig A, Kastrati A, et al.
Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention. European Heart Journal. 2008;29(12):1504-9.

Stefanescu A, Braun S, Ndrepepa G, Koppara T, Pavaci H, Mehilli J, et al.
Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. American Heart Journal. 2008;155(2):356-60.

Stein A, Wessling G, Deisenhofer I, Busch G, Steppich B, Estner H, et al.
Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization. Europace. 2008;10(4):444-9.

Voeller H, Braun S. 
Neue Aspekte des INR-Selbstmonitorings. Haemostaseologie. 2008;28(4):231-3.
 

2007

Boehm JMD, Grammer JBPD, Lehnert FMD, Dietrich WMDPD, Wagenpfeil SPD, Wildhirt SMMDPD, et al.
Factor V Leiden Does Not Affect Bleeding in Aprotinin Recipients after Cardiopulmonary Bypass. Anesthesiology. 2007;106(4):681-6.

Braun S, Watzke H, Hasenkam JM, Schwab M, Wolf T, Dovifat C, et al.
Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thrombosis and Haemostasis. 2007;97(2):310-4.

Braun SL, Eicken A, Kaemmerer H. 
Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.  International journal of cardiology. 2007;116(2):e74-5.

Braun SL, Soppa C, Taborski U, Völler H.
Qualitätssicherung der Patientenschulung zur Selbstkontrolle der Antikoagulation. Z ärztl Fortbild Qual Gesundhwes. 2007;101:194-5.

Ndrepepa G, Braun S, Mehilli J, Niemöller K, Schömig A, Kastrati A.
A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes. Clinical Research in Cardiology. 2007;V96(1):30-7.

Ndrepepa G, Braun S, Schömig A, Kastrati A.
Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease. Am J Cardiol. 2007;100(4):578-.

Wiesner G, Barankay A, Braun S, Tassani-Prell P. 
No Difference in Postoperative Cardiac Troponin T Between a Sevoflurane- or Midazolam-Supplemented Opioid Anesthetic in Patients Undergoing On-Pump Coronary Artery Bypass Graft Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2007;21(1):162-4.
 

2006

Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Nekolla S, Vogt W, et al.
N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis. The American Journal Of Cardiology. 2006;97(8):1151-6.

Ndrepepa G, Kastrati A, Braun S, Koch W, Kolling K, Mehilli J, et al.
A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease. Clinica Chimica Acta 2006;373(1-2):70-6.

Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemoller K, von Beckerath N, et al.
N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease. The American Journal Of Medicine. 2006;119(4):355.e1-e8.

Schreiber C, Dietrich W, Braun S, Kostolny M, Eicken A, Lange R.
Use of heparin upon reoperation in a pediatric patient with heparin-induced thrombocytopenia after disappearance of antibodies. Clinical Research in Cardiology. 2006;V95(7):379-82.

Vogt M, Klostermann B, Braun S, Busch R, Hess J, Frosner G, et al.
Prevalence and clinical role of GBV-C infection after cardiac surgery in childhood: A study on 414 patients. Journal of Infection. 2006;53(1):43-8.

Vogt M, Rifai M, Braun S, Busch R, Hess J, Frosner G, et al.
Epidemiology, risk factors and clinical role of TT virus infection in polytransfused patients after cardiac surgery in childhood: impact of HCV co infection. Journal Of Clinical Virology. 2006;36(1):82-3.
 

2005

Braun S, Ndrepepa G, von Beckerath N, Mehilli J, Gorchakova O, Vogt W, et al.
Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting. American Heart Journal. 2005;150(3):550-6.

Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, et al.
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. American Heart Journal. 2005;150(2):344-50.

Lang T, Bauters A, Braun SL, Potzsch B, von Pape K-W, Kolde H-J, et al.
Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagulation & Fibrinolysis. 2005;16(4):301-10.

Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, et al.
Platelet Adhesion Via Glycoprotein IIb Integrin Is Critical for Atheroprogression and Focal Cerebral Ischemia: An In Vivo Study in Mice Lacking Glycoprotein IIb. Circulation. 2005;112(8):1180-8.

Ndrepepa G, Braun S, Dibra A, Mehilli J, Vogt W, Schomig A, et al.
Iron status and clinical outcome in patients with coronary artery disease after coronary stenting. Nutrition, Metabolism, And Cardiovascular Diseases: NMCD. 2005;15(6):418-25.

Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Vogt W, Schomig A, et al.
Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction. The American Journal of Cardiology. 2005;95(5):553-7.

Ndrepepa G, Braun S, Niemoller K, Mehilli J, von Beckerath N, von Beckerath O, et al.
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Patients With Chronic Stable Angina. Circulation. 2005;112(14):2102-7.

Ndrepepa G, Braun S, von Beckerath N, Mehilli J, Gorchakova O, Vogt W, et al.
Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease. Clinica Chimica Acta; 2005;360(1-2):178-86.

Lammers A, Kaemmerer H, Hollweck R, Schneider R, Barthel P, Braun S, et al.
Impaired cardiac autonomic nervous activity predicts sudden cardiac death in patients with operated and unoperated congenital cardiac disease. The Journal Of Thoracic And Cardiovascular Surgery. 2006;132(3):647-55.
 

2004

Braun S, Ndrepepa G, Beckerath Nv Nv, Vogt W, Schomig A, Kastrati A.
Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations. Atherosclerosis. 2004;174(1):105-10.

Braun SL, Ciolek K, Vogt W.
Early Detection of the Selectivity Loss of the Cobas Integra Analyzer Chloride Ion-Selective Electrode. Clinical Chemistry.  2004;50(7):1272-3.

Kaemmerer H, S Fratz, SL Braun, K Koelling, A Eicken, S Brodherr-Heberlein, K Pietrzik and J Hess.
Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease. Am J Cardiol. 2004;94(6):825-8.

Kolling K, Ndrepepa G, Koch W, Braun S, Mehilli J, Schomig A, et al.
Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B(12) levels and the extent of coronary artery disease. The American Journal Of Cardiology. 2004;93(10):1201-6.

Pinkau T, Mann JF, Ndrepepa G, Mehilli J, Hadamitzky M, Braun S, et al.
Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kidney Dis. 2004;44(4):627-35.

Taborski U, Braun SL, Völler H.
Analytical Performance of the New Coagulation Monitoring System INRatio™ for the Determination of INR Compared with the Coagulation Monitor Coaguchek® S and an Established Laboratory Method. Journal of Thrombosis and Thrombolysis. 2004;18(2):103-7.

Vogt M, Muhlbauer F, Braun SL, Lang T, Busch R, Lange R, et al.
Prevalence and Risk Factors of Hepatitis C Infection after Cardiac Surgery in Childhood before and after Blood Donor Screening. Infection. 2004;32(3):134-7.

Von Beckerath N, Koch W, Mehilli J, Gorchakova O, Braun S, Schomig A, et al.
ABO locus O1 allele and risk of myocardial infarction. Blood Coagulation & Fibrinolysis 2004;15(1):61-7.